Jeffrey Riley
Direktor/Vorstandsmitglied bei GAIN THERAPEUTICS, INC.
Vermögen: 76 500 $ am 31.05.2024
Aktive Positionen von Jeffrey Riley
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| GAIN THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 01.05.2019 | - |
| Independent Dir/Board Member | 01.05.2019 | - | |
| Black Crow Ventures LLC | Corporate Officer/Principal | 01.11.2009 | - |
GT Gain Therapeutics SA
 GT Gain Therapeutics SA Pharmaceuticals: MajorHealth Technology GT Gain Therapeutics SA operates as a preclinical stage biotech firm developing a class of next generation brain-penetrant non-competitive pharmacological chaperones for the treatment of devastating diseases using the proprietary SEE-Tx technology. Its projects include Beta-galactosidase GLB1 gene and Glucosylceramidase GBA gene. The company was founded by Lorenzo Leoni and is headquartered in Lugano, Switzerland. | Direktor/Vorstandsmitglied | 11.09.2019 | - |
| Independent Dir/Board Member | 11.09.2019 | - | |
BlinkTBI, Inc.
 BlinkTBI, Inc. Data Processing ServicesTechnology Services Blinktbi, Inc. engages in the development of a eye test technology that provides objective data about neurological function to support medical personnel. The company was is headquartered in Charleston, SC. | Direktor/Vorstandsmitglied | 27.08.2020 | - |
| Vorstandsvorsitzender | 27.08.2020 | - | |
| CaraVan Biologix | Direktor/Vorstandsmitglied | 01.09.2021 | - |
Karriereverlauf von Jeffrey Riley
Ehemalige bekannte Positionen von Jeffrey Riley
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| THERIVA BIOLOGICS, INC. | Direktor/Vorstandsmitglied | 17.03.2010 | 05.12.2017 |
| Vorstandsvorsitzender | 07.02.2012 | 05.12.2017 | |
| Vorsitzender | 01.11.2011 | 14.05.2012 | |
| Independent Dir/Board Member | 16.03.2010 | 08.02.2012 | |
| Präsident | 07.02.2012 | 05.12.2017 | |
| 526 Ventures LLC | Gründer | 01.11.2009 | 01.01.2012 |
| Corporate Officer/Principal | 01.11.2009 | 01.01.2012 | |
Amphora Discovery Corp.
 Amphora Discovery Corp. Pharmaceuticals: MajorHealth Technology Amphora Discovery Corp. develops and manufactures pharmaceutical products. It provides custom assay development and enzymology services. The company provides drug discovery contract research services, HTS, profiling and lead generation services. The company was founded in September 2001 and is headquartered in Durham, NC. | Finanzdirektor/CFO | - | 24.03.2010 |
| TELESSO TECHNOLOGIES LTD. | Präsident | - | 30.06.2009 |
| ░░░░░░░░░░ ░░░░░░░░░░ ░░░░░ ░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
| ░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | - |
Ausbildung von Jeffrey Riley
| Boise State University | Undergraduate Degree |
| Thunderbird School of Global Management | Masters Business Admin |
Statistik
International
| Vereinigte Staaten | 11 |
| Australien | 3 |
| Schweiz | 2 |
Operativ
| Director/Board Member | 5 |
| Independent Dir/Board Member | 3 |
| Corporate Officer/Principal | 3 |
Sektoral
| Health Technology | 6 |
| Consumer Services | 3 |
| Health Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| THERIVA BIOLOGICS, INC. | Health Technology |
| GAIN THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 9 |
|---|---|
Amphora Discovery Corp.
Amphora Discovery Corp. Pharmaceuticals: MajorHealth Technology Amphora Discovery Corp. develops and manufactures pharmaceutical products. It provides custom assay development and enzymology services. The company provides drug discovery contract research services, HTS, profiling and lead generation services. The company was founded in September 2001 and is headquartered in Durham, NC. | Health Technology |
Nichols Institute Diagnostics
 Nichols Institute Diagnostics Medical/Nursing ServicesHealth Services Nichols Institute Diagnostics engages in manufacturing and marketing immunoassay systems utilizing direct label chemiluminescence and immunoradiometric technology. The company is headquartered in San Clemente, CA. | Health Services |
Telesso Technologies Ltd.
 Telesso Technologies Ltd. Pharmaceuticals: OtherHealth Technology Telesso Technologies Ltd. was engaged in biotechnology research and development. The company was founded on December 15, 1995 and was headquartered in Melbourne, Australia. | Health Technology |
| Black Crow Ventures LLC | |
| 526 Ventures LLC | |
Queensland BioCapital Funds Pty Ltd.
 Queensland BioCapital Funds Pty Ltd. Investment ManagersFinance Queensland BioCapital Funds Pty Ltd. (QBF) is the venture capital arm of Queensland Investment Corporation, a Queensland Government-owned corporation. QBF established in 2002, located in Australia. | Finance |
GT Gain Therapeutics SA
GT Gain Therapeutics SA Pharmaceuticals: MajorHealth Technology GT Gain Therapeutics SA operates as a preclinical stage biotech firm developing a class of next generation brain-penetrant non-competitive pharmacological chaperones for the treatment of devastating diseases using the proprietary SEE-Tx technology. Its projects include Beta-galactosidase GLB1 gene and Glucosylceramidase GBA gene. The company was founded by Lorenzo Leoni and is headquartered in Lugano, Switzerland. | Health Technology |
BlinkTBI, Inc.
BlinkTBI, Inc. Data Processing ServicesTechnology Services Blinktbi, Inc. engages in the development of a eye test technology that provides objective data about neurological function to support medical personnel. The company was is headquartered in Charleston, SC. | Technology Services |
| CaraVan Biologix |
- Börse
- Insiders
- Jeffrey Riley
- Erfahrung